How will work travel frequency affect medication consistency and meal planning
The trial ran for a little over a year and showed an average decrease in BMI of 16% (compared to 0.6% for placebo)
These medications: reduce appetite lower inflammation improve liver fat improve metabolic markers reduce cardiovascular events (SELECT trial) They do not : build muscle increase VO max improve mitochondrial function replace strength training fix metabolic flexibility guarantee long-term weight maintenance 2
Gallbladder and Pancreas Concerns Some patients have reported gallbladder problems, such as gallstones or gallbladder inflammation
Decreased Muscle Mass Without intervention, women lose approximately 3-5% of muscle mass per decade after age 30
After matching women by age, race, ethnicity, body mass index, breast density and type 2 diabetes status, GLP-1 use remained associated with lower breast cancer incidence